- Home
- CMMB vs JVA Comparison
CMMB vs JVA Comparison
Compare CMMB & JVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMMB
- JVA
- Stock Information
- Founded
- CMMB 2004
- JVA 1971
- Country
- CMMB Israel
- JVA United States
- Employees
- CMMB N/A
- JVA N/A
- Industry
- CMMB Biotechnology: Pharmaceutical Preparations
- JVA Packaged Foods
- Sector
- CMMB Health Care
- JVA Consumer Staples
- Exchange
- CMMB Nasdaq
- JVA Nasdaq
- Market Cap
- CMMB 15.8M
- JVA 14.7M
- IPO Year
- CMMB N/A
- JVA 2005
- Fundamental
- Price
- CMMB $1.31
- JVA $3.01
- Analyst Decision
- CMMB Strong Buy
- JVA
- Analyst Count
- CMMB 3
- JVA 0
- Target Price
- CMMB $5.67
- JVA N/A
- AVG Volume (30 Days)
- CMMB 209.5K
- JVA 179.0K
- Earning Date
- CMMB 11-07-2024
- JVA 10-18-2024
- Dividend Yield
- CMMB N/A
- JVA N/A
- EPS Growth
- CMMB N/A
- JVA N/A
- EPS
- CMMB N/A
- JVA 0.20
- Revenue
- CMMB N/A
- JVA $76,111,698.00
- Revenue This Year
- CMMB N/A
- JVA N/A
- Revenue Next Year
- CMMB N/A
- JVA N/A
- P/E Ratio
- CMMB N/A
- JVA $14.73
- Revenue Growth
- CMMB N/A
- JVA 17.27
- 52 Week Low
- CMMB $0.42
- JVA $0.67
- 52 Week High
- CMMB $2.55
- JVA $3.88
- Technical
- Relative Strength Index (RSI)
- CMMB 36.04
- JVA 46.02
- Support Level
- CMMB $1.31
- JVA $2.69
- Resistance Level
- CMMB $1.59
- JVA $3.12
- Average True Range (ATR)
- CMMB 0.16
- JVA 0.23
- MACD
- CMMB -0.04
- JVA -0.09
- Stochastic Oscillator
- CMMB 12.24
- JVA 3.81
About CMMB Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life threatening fibrotic and inflammatory diseases. It is advancing three Phase 2 clinical trials in parallel for CM-101 treating rare fibrotic conditions.
About JVA Coffee Holding Co. Inc.
Coffee Holding Co Inc is engaged in the business of wholesale coffee operations, including manufacturing, roasting, packaging, marketing and distributing roasted and blended coffees for private labeled accounts and its own brands, and it sells green coffee. Its products include wholesale green coffee, private-label coffee, and branded coffee. The company sells its coffee products throughout the United States, Canada and certain countries in Asia.